AHA Scientific Sessions 2022 Late-Breaking Science Coverage

Published: 02 November 2022

  • Views:

    Views Icon 4990

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Stay updated with the latest data in cardiovascular science with the help of recognised experts and new voices offering practical summaries, in-depth discussions and critical reviews.

 

With their fingers on the pulse of cardiovascular innovation, Prof Van Mieghem and Dr Daemen offer their succinct and insightful take on the most expected trials of AHA 22 in their regular review series View from the Thoraxcenter.

 

Dr Harriette Van Spall, recipient of this year’s AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they talk about methodology, results, and impact on patient care.

 

This year we partner with @CardioNerds to bring the fresh perspective of a great team founded to democratize cardiovascular education. Get the most of the new data from an interview series featuring principal investigators and trainees from the CardioNerds family.

 

Look behind the scientific achievement and learn more about the personal motivations of some of the investigators, benefit from their advice for early career researchers through our Behind the Heart series.

 

More from this programme

Part 1

View from the Thoraxcenter: Review Series

In this dynamic late-breaking science preview Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of the AHA Scientific Sessions.
2 sessions
What's Hot at AHA22? Late-Breaking Science Wrap-up Watch now
What's Hot at AHA22? Late-Breaking Science Preview Watch now

Part 2

Late-breaker Discussions With Harriette Van Spall

Dr Harriette Van Spall, recipient of this year’s AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they talk about methodology, results, and impact on patient care.
3 sessions
The TRANSFORM-HF Trial WIth Dr Van Spall & Dr Mentz Watch now
The STRONG-HF Trial With Dr Van Spall & Prof Mebazaa Watch now
The PRECISE Trial With Dr Van Spall & Dr Douglas Watch now

Part 3

Expert Interviews

Late-breaking science methodology, results and implications for practice and research under 10 minutes.
7 sessions
CRISPR-Cas9 In Vivo Gene Editing in Pts With ATTR Amyloidosis With Cardiomyopathy Watch now
EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation Watch now
BT001 PIVOTAL: nCBT in Pts with Type II Diabetes Watch now
PRECISION: Aprocitentan in the Treatment of Resistant Hypertension Watch now
NOVA: Botulinium Toxin Type A in Patients with Post-Operative Atrial Fibrillation Watch now
EMPEROR-POOLED: Clinical Outcomes & Efficacy of Empagliflozin in Black vs White Pts With HF Watch now
SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension Watch now

Part 4

Radcliffe & CardioNerds @AHA22

This year we partner with @CardioNerds to bring the fresh perspective of a great team founded to democratize cardiovascular education. Get the most of the new data from an interview series featuring principal investigators and trainees from the CardioNerds family.
8 sessions
The PROMINENT Trial With Dr Kaur & Dr Pradhan Watch now
The OCEAN(a)-DOSE Trial With Dr Gurleen Kaur & Dr Michelle L O'Donoghue Watch now
The EMPA-Kidney Trial With Dr Wilcox & Dr Preiss Watch now
The PREVENT-HD Randomized Clinical Trial With Dr Fadah & Dr Piazza Watch now
The RESPECT EPA Trial With Prof Daida & Dr Jumkhawala Watch now
The PROGRESSIVE-AF Trial With Dr Wilcox & Dr Andrade Watch now
The ECMO-CS Trial With Dr Ostadal & Dr Jumkhawala Watch now
The IRONMAN Trial With Dr Amir & Dr Kalra Watch now

Part 5

Behind the Heart

4 sessions
Being a Researcher With Investigator, Dr Julian Gillmore Watch now
Research in 2022 With Investigator, Dr Shino Kany Watch now
Making a Difference With Physician-Scientist, Dr Schlaich Watch now
What Makes Dr Bonaca excited about CV Science in 2022? Watch now

Part 6

AHA22 Highlights

2 sessions
Late-breaking Science Highlights With Dr Joseph A Hill Watch now
4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag Watch now

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved…

View full profile
Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile